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irchow’s Metamorphosis
evealed
riglycerides in the Heart*
einrich Taegtmeyer, MD, DPHIL, FACC,
omain Harmancey, PHD
ouston, Texas
he essence of cardiac metabolism is easy to understand: in
he normal human heart, supply and demand of energy-
roviding substrates is finely balanced to meet the energy
eeds for contraction by oxidative metabolism of fatty acids
nd carbohydrates. When it comes to energy, the heart is
lways on fire, although the relative contribution of different
uels to the fire may differ substantially depending on a
umber of environmental factors. The concentrations of
ubstrates in the blood, the concentrations of hormones,
dipokines and cytokines, oxygen supply, contractile force of
he heart, and the metabolic needs of the body are all factors
hat determine rates of substrate uptake and use by the heart
1). In the end, however, the system takes care of itself by
alancing substrate uptake at the level of the sarcolemma
nd substrate use, mostly at the level of the mitochondria.
See page 1006
It has been known for over one-half of a century that the
uman heart, with the body at rest and after an overnight
ast, oxidizes mostly fatty acids to meet its energy needs for
ontraction (2). What holds true for the heart in vivo also is
vident in the heart ex vivo (3). In a setting of controlled
ubstrate supply, fatty acids suppress glucose oxidation (4)
nd glucose suppresses fatty acid oxidation (3). In short,
here is a highly regulated interplay of substrates, with fatty
cids dominating the fuels for respiration.
A further determinant of energy substrate metabolism is
he metabolic state of the organism as a whole. A case in
oint is short-term starvation. Another case in point is
nsulin-resistant diabetes. Both conditions are characterized
y an oversupply of fuels in the bloodstream—starvation
obilizes fatty acids from adipose tissue, whereas insulin-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.e
From the Department of Internal Medicine, Division of Cardiology, The Univer-
ity of Texas Medical School at Houston, Houston, Texas.esistant diabetes tissues fail to use fuels efficiently. Heart
uscle, like the body as a whole, develops insulin resistance.
lthough insulin resistance is a marker for poor prognosis in
eart diseases, in metabolic terms insulin resistance may
ctually protect the cardiomyocyte from an oversupply of
uel. Triglyceride accumulation in insulin-resistant muscle
ust not be confused with fatty atrophy already described in
858 by Virchow (5) as a “true metamorphosis of the heart
uscle cell” and recently redefined in failing human heart
uscle of patients undergoing cardiac transplantation (6)
nd in animal models lacking certain forms of lipases (7,8).
The study by Hammer et al. (9) in this issue of the Journal
raws attention to the dynamic nature of triglyceride turn-
ver. The study is the result of exciting new technology
sing metabolic imaging in the form of proton magnetic
esonance spectroscopy (10). The investigators have previ-
usly shown that short-term starvation results in myocardial
riglyceride accumulation (11). They now show that long-
erm starvation reverses high triglyceride levels in the hearts
f patients with insulin-dependent diabetes. It is not always
ppreciated that the mammalian heart is capable of taking
p triglycerides (12) and also of releasing triglycerides (13).
n other words, the heart loves its fatty acids for energy
rovision, but it also loves to get rid of them when they are
resent in excess.
A word of caution is in order. Despite evidence for
ntramyocellular triglyceride accumulation and impaired
iastolic function, it is still not proven that this metabolic
eature is directly linked to the development of heart failure.
f animal studies can be trusted, decreased delivery of fatty
cids reverses triglyceride accumulation and contractile dys-
unction (14,15). The present study extends these observa-
ions to the human heart, where a decreased plasma fatty
cid content is associated with a decrease in myocardial
riglyceride levels.
However, there is also evidence to support the idea that
hanneling fatty acids to triacylglycerol synthesis is diverting
ipids from toxic metabolic pathways, such as de novo
eramide synthesis, which mediates programmed cell death
16). In skeletal muscle, the intramyocellular triglyceride
evels are increased in endurance-trained subjects who show
igh insulin sensitivity. The “athletes’ paradox” has led to
he recently reviewed concept proposing that a lower
ntramyocellular triglyceride turnover, rather than the
ntramyocellular triglyceride levels per se, is a determi-
ant for impaired insulin sensitivity in muscle from obese
eople (17).
Despite these limitations, the study is important for 3
easons. First, it shows the dynamic nature of triglyceride
etabolism within the cardiomyocyte. Second, increased
riglyceride levels in the heart may be associated with
mpaired diastolic function, but they are not predicating
eart failure (in this point we disagree with the authors’
nterpretation of their results). Third, there is growing
vidence in the biology of aging that caloric restriction
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Editorial Comment September 16, 2008:1013–4mproves the life span, even in obese animals placed on
aloric restriction (18). So, there is hope for all of us caught
p in the “obesity epidemic.” We now know one more
mportant aspect of heart metabolism: the dynamic nature
f myocardial triglyceride turnover.
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